A Study of GZR18 Injection in Chinese Obese/Overweight Patients

NCT06256536 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: GZR18
OTHER: Placebo

Sponsor

Gan and Lee Pharmaceuticals, USA